Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edgar Carnero Contentti

Showing results (11-20 of 146) with videos related to

Pageof 15
Sort By:
Journal of Neuroinflammation|September 17, 2021
Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategiesEdgar Carnero Contentti, Jorge Correale
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 7, 2025
Persistent gadolinium enhancement: An emerging MRI feature in NMOSD?Edgar Carnero Contentti, Verónica Tkachuk
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 3, 2020
Spinal cord and brain MRI should be routinely performed during follow-up in patients with NMOSD - YesEdgar Carnero Contentti, Jorge Correale
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 29, 2022
Association between infections, the microbiome, vaccination, and neuromyelitis optica spectrum disorderEdgar Carnero Contentti, Jorge Correale
Journal of Neuroimmunology|December 3, 2025
Limited availability of live CBA for AQP4-IgG testing and its consequences for the diagnosis and treatment of NMOSD in Latin American countriesVinícius Boldrini, Edgar Carnero Contentti
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 10, 2024
MRI of the relevant domain should be performed to confirm whether clinical symptoms represent an attack of NMOSD: YesEdgar Carnero Contentti, Dean M Wingerchuk
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 22, 2020
Barriers to access and utilization of multiple sclerosis care services in a large cohort of Latin American patientsEdgar Carnero Contentti, Susana Giachello, Jorge Correale
Expert Opinion on Emerging Drugs|April 16, 2021
Emerging drugs for the treatment of adult MOG-IgG-associated diseasesEdgar Carnero Contentti, Mariano Marrodan, Jorge Correale
Immunology|July 1, 2021
Interleukin-35 is a critical regulator of immunity during helminth infections associated with multiple sclerosisJorge Correale, Mariano Marrodan, Edgar Carnero Contentti
Frontiers in Neurology|December 15, 2023
Editorial: Real-world study of multiple sclerosis and related diseases in developing countriesJinming Han, Edgar Carnero Contentti, Ju Liu
Pageof 15

Showing results (11-20 of 146) with videos related to

Sort By:
Pageof 15
Journal of Neuroinflammation|September 17, 2021
Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategiesEdgar Carnero Contentti, Jorge Correale
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 7, 2025
Persistent gadolinium enhancement: An emerging MRI feature in NMOSD?Edgar Carnero Contentti, Verónica Tkachuk
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 3, 2020
Spinal cord and brain MRI should be routinely performed during follow-up in patients with NMOSD - YesEdgar Carnero Contentti, Jorge Correale
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 29, 2022
Association between infections, the microbiome, vaccination, and neuromyelitis optica spectrum disorderEdgar Carnero Contentti, Jorge Correale
Journal of Neuroimmunology|December 3, 2025
Limited availability of live CBA for AQP4-IgG testing and its consequences for the diagnosis and treatment of NMOSD in Latin American countriesVinícius Boldrini, Edgar Carnero Contentti
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 10, 2024
MRI of the relevant domain should be performed to confirm whether clinical symptoms represent an attack of NMOSD: YesEdgar Carnero Contentti, Dean M Wingerchuk
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 22, 2020
Barriers to access and utilization of multiple sclerosis care services in a large cohort of Latin American patientsEdgar Carnero Contentti, Susana Giachello, Jorge Correale
Expert Opinion on Emerging Drugs|April 16, 2021
Emerging drugs for the treatment of adult MOG-IgG-associated diseasesEdgar Carnero Contentti, Mariano Marrodan, Jorge Correale
Immunology|July 1, 2021
Interleukin-35 is a critical regulator of immunity during helminth infections associated with multiple sclerosisJorge Correale, Mariano Marrodan, Edgar Carnero Contentti
Frontiers in Neurology|December 15, 2023
Editorial: Real-world study of multiple sclerosis and related diseases in developing countriesJinming Han, Edgar Carnero Contentti, Ju Liu
Pageof 15